These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25903572)

  • 21. Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains.
    Shallom SJ; Zelazny AM
    J Clin Microbiol; 2022 Apr; 60(4):e0169421. PubMed ID: 35313731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and assessment of clarithromycin inducible resistant strains among Korean Mycobacterium abscessus clinical strains: PCR methods.
    Lee SH; Yoo HK; Kim SH; Koh WJ; Kim CK; Park YK; Kim HJ
    J Clin Lab Anal; 2014 Sep; 28(5):409-14. PubMed ID: 24652818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
    Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
    Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex.
    Bouzinbi N; Marcy O; Bertolotti T; Chiron R; Bemer P; Pestel-Caron M; Peuchant O; Guet-Revillet H; Fangous MS; Héry-Arnaud G; Ouedraogo AS; Bañuls AL; Godreuil S
    PLoS One; 2020; 15(9):e0239146. PubMed ID: 32976521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
    Nash KA; Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1367-76. PubMed ID: 19171799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?
    Hanson KE; Slechta ES; Muir H; Barker AP
    J Clin Microbiol; 2014 May; 52(5):1705-7. PubMed ID: 24554745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus.
    Realegeno S; Mirasol R; Garner OB; Yang S
    J Mol Diagn; 2021 Nov; 23(11):1460-1467. PubMed ID: 34454109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
    Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Kamada K; Yoshida A; Iguchi S; Arai Y; Uzawa Y; Konno S; Shimojima M; Kikuchi K
    Sci Rep; 2021 Jun; 11(1):12208. PubMed ID: 34108590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in
    Yoshida S; Tsuyuguchi K; Kobayashi T; Inoue Y; Suzuki K
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33570485
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.
    Bastian S; Veziris N; Roux AL; Brossier F; Gaillard JL; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2011 Feb; 55(2):775-81. PubMed ID: 21135185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.
    Yamaba Y; Takakuwa O; Saito M; Kawae D; Yoshihara M; Mori Y; Kunii E; Ito Y; Yoshida S; Akita K
    Intern Med; 2019 Sep; 58(18):2675-2678. PubMed ID: 31178483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.